Panbela Therapeutics Inc. (PBLA) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Panbela Therapeutics Inc. (PBLA)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

0.37

0.01 (1.37%)

At close: Jan 15, 2025, 10:02 AM

undefined% (undefined)

Bid	n/a
Market Cap	1.79M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-34.51
PE Ratio (ttm)	-0.01
Forward PE	n/a
Analyst	Hold

Ask	n/a
Volume	2
Avg. Volume (20D)	14,519
Open	0.37
Previous Close	0.36
Day's Range	0.37 - 0.37
52-Week Range	0.30 - 9.80
Beta	undefined

About PBLA

Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, ...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Jan 3, 2017

Employees 7

Stock Exchange NASDAQ

Ticker Symbol PBLA

Website https://www.panbela.com

Analyst Forecast

According to 2 analyst ratings, the average rating for PBLA stock is "Hold." The 12-month stock price forecast is $25, which is an increase of 6693.48% from the latest price.

Buy 50.00%

Hold 50.00%

Sell 0.00%

Stock Forecasts

News

2 months ago · seekingalpha.com

Panbela Therapeutics, Inc. (PBLA) Q3 2024 Earnings Call Transcript

Panbela Therapeutics, Inc. (OTCQB:PBLA) Q3 2024 Earnings Conference Call November 14, 2024 4:30 PM ET Company Participants Jennifer Simpson - CEO Sue Horvath - CFO Conference Call Participants Jonatha...